SciTropin A
Commercial- Indications
- Growth hormone deficiency
Company intelligence / Profile preview
SciGen Ltd is a Singapore-based biopharmaceutical company specializing in the development, manufacturing, marketing, and commercialization of innovative healthcare products—primarily biosimilar biologics and medical devices. The company's portfolio covers endocrinology, oncology, immunology and related fields. It has a global commercial presence with operations across Asia-Pacific and product registrations worldwide. In recent years it has expanded through acquisition of established brands/products from major pharma companies.
3 more assets in the full pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SciGen Ltd.